Product
Human Rabies Immune Globulin
1 clinical trial
6 indications
Indication
RabiesIndication
Infectious DiseaseIndication
Virus DiseasesIndication
Rhabdoviridae InfectionsIndication
Mononegavirales InfectionsIndication
RNA Virus InfectionsClinical trial
A Phase III Randomized Blinded Study to Evaluate SYN023 Compared to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies in Adults With Category III Rabies Exposure RisksStatus: Completed, Estimated PCD: 2022-06-24